is...(horny for cash)
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
MBHIP,,,grab these in .90's whooppy doo! 3 weeks ago AH 6.99$
lil brother might be next MBHI
Took down chart yesterday,,
RHIE went nutz
PRMO micro penny good VOL
MBHIP 6.99 AH's
whoopty mutha fuckin dooo!
Would think mbhi next to blow up!
shitz 2 ez ehhh.
Fuk yeah, look at RF when they sold Me shares for 4 bones... Ez
ouch....ALLin this a.m. crxx, nice call lj.
ffgo says .003 a share
Am i the only 1 reading the new news 2nite?
should be nice monday..B lucky to grab sum 1's 2's tooo even 3's
FFGOFortress Financial Group, Inc. -- Possible Increase in Sale Price of Gold Interests
Date : 04/09/2010 @ 12:09PM
Source : MarketWire
Stock : Fortress Financial Group, Inc. (FFGO)
Quote : 0.0001 0.0 (0.00%) @ 8:08AM
Fortress Financial Group, Inc. -- Possible Increase in Sale Price of Gold Interests
LAS VEGAS, NV -- (Marketwire)
04/09/10
Fortress Financial Group, Inc. (PINKSHEETS: FFGO) confirms that should the price of Gold continue to rise; the sale of the Company's Gold interests this month will be executed at a higher price. We had priced the sale transactions at a Gold price of US$1,050/oz. With the price of Gold exceeding a price of US$1,160/oz in today's trading; the value of the sale will now in all likelihood be considerably higher than the forecasted lowest price published by the Company that equated to a price of US$0.003 per share of the Company's Common Stock. Our agreements provided for this event, should the price of Gold trade higher than anticipated at the time of the agreements.
This is conditional upon Gold maintaining a level considerably higher than US$1,050/oz. Management feels very confident that will be case, therefore leading us to revise our forecasts upwards in respect of these sale transactions and the price per share obtained for our stockholders.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may," "future," "plan" or "planned," "will" or "should," "expected," "anticipates," "draft," "eventually," "projected" or "guidelines." You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors and other risks identified in filings made by such company with the SEC.
Contact:
Fortress Financial Group, Inc.
Peter J. Bezzano
Chairman
E Mail: admin@fortfinancegroup.com
Twitter: http://twitter.com/FFGO
Telephone: (954) 623-7409
All Investor Related Enquiries:
Corporate Communications to Fortress - Global Investor Relations
E Mail: ir@fortfinancegroup.com
Direct Line: (407) 403-5565
Fortress Financial Group, Inc. -- Possible Increase in Sale Price of Gold Interests
Date : 04/09/2010 @ 12:09PM
Source : MarketWire
Stock : Fortress Financial Group, Inc. (FFGO)
Quote : 0.0001 0.0 (0.00%) @ 8:08AM
Fortress Financial Group, Inc. -- Possible Increase in Sale Price of Gold Interests
LAS VEGAS, NV -- (Marketwire)
04/09/10
Fortress Financial Group, Inc. (PINKSHEETS: FFGO) confirms that should the price of Gold continue to rise; the sale of the Company's Gold interests this month will be executed at a higher price. We had priced the sale transactions at a Gold price of US$1,050/oz. With the price of Gold exceeding a price of US$1,160/oz in today's trading; the value of the sale will now in all likelihood be considerably higher than the forecasted lowest price published by the Company that equated to a price of US$0.003 per share of the Company's Common Stock. Our agreements provided for this event, should the price of Gold trade higher than anticipated at the time of the agreements.
This is conditional upon Gold maintaining a level considerably higher than US$1,050/oz. Management feels very confident that will be case, therefore leading us to revise our forecasts upwards in respect of these sale transactions and the price per share obtained for our stockholders.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may," "future," "plan" or "planned," "will" or "should," "expected," "anticipates," "draft," "eventually," "projected" or "guidelines." You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors and other risks identified in filings made by such company with the SEC.
Contact:
Fortress Financial Group, Inc.
Peter J. Bezzano
Chairman
E Mail: admin@fortfinancegroup.com
Twitter: http://twitter.com/FFGO
Telephone: (954) 623-7409
All Investor Related Enquiries:
Corporate Communications to Fortress - Global Investor Relations
E Mail: ir@fortfinancegroup.com
Direct Line: (407) 403-5565
LLY (cymbalta)
will take care of u LJ
Wify got back from doctors office with a box of this stuff
1 pill treats multiple problems.
New pill on the market
This stock is gonna rock
http://www.cymbalta.com/index.jsp
board
http://ih.advfn.com/p.php?pid=squote&symbol=LLY
* Depression
o Understanding Depression
o The Impact of Depression
o The Journey to Improvement
o Cymbalta and Depression
o Information for Friends and Family
* Generalized Anxiety Disorder
o Understanding Generalized Anxiety Disorder
o The Impact of Generalized Anxiety Disorder
o The Journey to Improvement
o Cymbalta and Generalized Anxiety Disorder
o Information for Friends and Family
* Diabetic Nerve Pain
o Understanding Diabetic Nerve Pain
o The Impact of Diabetic Nerve Pain
o The Journey to Improvement
o Cymbalta and Diabetic Nerve Pain
o Information for Friends and Family
* Fibromyalgia
o Understanding Fibromyalgia
o How Fibromyalgia May Affect You
o The Journey to Improvement
o Cymbalta and Fibromyalgia
o Information for Friends and Family
* Learn About Cymbalta
o How Cymbalta Is Believed to Work
o What to Expect
o Resource Center
o Important Safety Information
o Side Effects
o Commonly Asked Questions About Cymbalta
o Contact Us
o About Lilly
* Already Prescribed Cymbalta
o Managing Your Depression
o Treating Your Generalized Anxiety Disorder
o Managing Your Diabetic Nerve Pain
o Managing Your Fibromyalgia
Home > Home
Already Prescribed Cymbalta?
Learn how Cymbalta can help treat or manage your symptoms. More
I have been prescribed Cymbalta for:
Free Cymbalta Sample
Receive a free sample of Cymbalta with your doctor's prescription
Cymbalta News
Cymbalta is now approved for the maintenance treatment of GAD. Read the official news release
* Depression Impact Tool
* Diabetic Nerve Pain Impact Tool
* Fibromyalgia Doctor Discussion Guide
* Get a Free Sample of Cymbalta
* Resource Center
* Cymbalta and Depression
* Cymbalta and Generalized Anxiety Disorder
* Cymbalta and Diabetic Nerve Pain
* Cymbalta and Fibromyalgia
Indication
Cymbalta is indicated for the treatment of major depressive disorder (MDD). The efficacy of Cymbalta was established in four short-term and one maintenance trial in adults.
Cymbalta is indicated for the treatment of generalized anxiety disorder (GAD). The efficacy of Cymbalta was established in three short-term and one maintenance trial in adults.
Cymbalta is indicated for the management of diabetic peripheral neuropathic pain and fibromyalgia.
Important Safety Information About Cymbalta
Antidepressants can increase suicidal thoughts and behaviors in children, teens, and young adults. Suicide is a known risk of depression and some other psychiatric disorders. Call your doctor right away if you have new or worsening depression symptoms, unusual changes in behavior, or thoughts of suicide. Be especially observant within the first few months of treatment or after a change in dose. Approved only for adults 18 and over.
What should I talk about with my healthcare provider?
Patients on antidepressants and their families or caregivers should watch for new or worsening depression symptoms, unusual changes in behavior, thoughts of suicide, anxiety, agitation, panic attacks, difficulty sleeping, irritability, hostility, aggressiveness, impulsivity, restlessness, or extreme hyperactivity. Call your healthcare provider right away if you have thoughts of suicide or if any of these symptoms are severe or occur suddenly. Be especially observant within the first few months of antidepressant treatment or whenever there is a change in dose.
Who should NOT take Cymbalta?
You should not take Cymbalta if:
* You have recently taken a type of antidepressant called a monoamine oxidase inhibitor (MAOI)
* You have uncontrolled narrow-angle glaucoma (increased eye pressure)
* You are taking Mellaril® (thioridazine)
What other important information should I discuss with my healthcare provider?
Before starting Cymbalta, talk with your healthcare provider:
* about all of your medical conditions, including kidney or liver problems, glaucoma, diabetes, seizures, or if you have bipolar disorder. Cymbalta may worsen a type of glaucoma or the control of blood sugar in some patients with diabetes
* about your alcohol use
* if you are taking nonprescription or prescription medicines, including those for migraine, to address a possible life-threatening condition
* if you are taking NSAID pain relievers, aspirin, or blood thinners. Use with Cymbalta may increase bleeding risk
* if you are pregnant, plan to become pregnant during therapy, or are breastfeeding an infant
While taking Cymbalta, talk with your healthcare provider:
* if you have itching, right upper belly pain, dark urine, yellow skin/eyes, or unexplained flu-like symptoms, which may be signs of liver problems. Severe liver problems, sometimes fatal, have been reported
* if you have high fever, confusion, and stiff muscles to address a possible life-threatening condition
* before stopping Cymbalta or changing your dose
* if you experience dizziness or fainting upon standing, especially when first starting Cymbalta or when increasing the dose
* about your blood pressure. Cymbalta can increase your blood pressure. Your healthcare provider should check your blood pressure prior to and while taking Cymbalta
* if you experience headache, weakness, confusion, problems concentrating, memory problems, or feel unsteady while taking Cymbalta which may be signs of low sodium levels
* if you develop problems with urine flow
If you have any questions, talk to your healthcare provider before taking Cymbalta.
What are the possible side effects of Cymbalta?
The most common side effect of Cymbalta was nausea. Other common side effects included dry mouth, sleepiness, constipation, decreased appetite, and, increased sweating. This is not a complete list of side effects.
Other safety information about Cymbalta:
Cymbalta may cause sleepiness and dizziness. Until you know how Cymbalta affects you, you should not drive a car or operate hazardous machinery.
Please read additional Safety Information and Boxed Warning for a complete list.
Prescribing Information | Safety Information and Boxed Warning | Medication Guide | Multimedia Help | Glossary | Site Map | Patient Assistance Program
Lilly
LLY (cymbalta)
will take care of u LJ
Wify got back from doctors office with a box of this stuff
1 pill treats multiple problems.
New pill on the market
This stock is gonna rock
http://www.cymbalta.com/index.jsp
board
http://ih.advfn.com/p.php?pid=squote&symbol=LLY
* Depression
o Understanding Depression
o The Impact of Depression
o The Journey to Improvement
o Cymbalta and Depression
o Information for Friends and Family
* Generalized Anxiety Disorder
o Understanding Generalized Anxiety Disorder
o The Impact of Generalized Anxiety Disorder
o The Journey to Improvement
o Cymbalta and Generalized Anxiety Disorder
o Information for Friends and Family
* Diabetic Nerve Pain
o Understanding Diabetic Nerve Pain
o The Impact of Diabetic Nerve Pain
o The Journey to Improvement
o Cymbalta and Diabetic Nerve Pain
o Information for Friends and Family
* Fibromyalgia
o Understanding Fibromyalgia
o How Fibromyalgia May Affect You
o The Journey to Improvement
o Cymbalta and Fibromyalgia
o Information for Friends and Family
* Learn About Cymbalta
o How Cymbalta Is Believed to Work
o What to Expect
o Resource Center
o Important Safety Information
o Side Effects
o Commonly Asked Questions About Cymbalta
o Contact Us
o About Lilly
* Already Prescribed Cymbalta
o Managing Your Depression
o Treating Your Generalized Anxiety Disorder
o Managing Your Diabetic Nerve Pain
o Managing Your Fibromyalgia
Home > Home
Already Prescribed Cymbalta?
Learn how Cymbalta can help treat or manage your symptoms. More
I have been prescribed Cymbalta for:
Free Cymbalta Sample
Receive a free sample of Cymbalta with your doctor's prescription
Cymbalta News
Cymbalta is now approved for the maintenance treatment of GAD. Read the official news release
* Depression Impact Tool
* Diabetic Nerve Pain Impact Tool
* Fibromyalgia Doctor Discussion Guide
* Get a Free Sample of Cymbalta
* Resource Center
* Cymbalta and Depression
* Cymbalta and Generalized Anxiety Disorder
* Cymbalta and Diabetic Nerve Pain
* Cymbalta and Fibromyalgia
Indication
Cymbalta is indicated for the treatment of major depressive disorder (MDD). The efficacy of Cymbalta was established in four short-term and one maintenance trial in adults.
Cymbalta is indicated for the treatment of generalized anxiety disorder (GAD). The efficacy of Cymbalta was established in three short-term and one maintenance trial in adults.
Cymbalta is indicated for the management of diabetic peripheral neuropathic pain and fibromyalgia.
Important Safety Information About Cymbalta
Antidepressants can increase suicidal thoughts and behaviors in children, teens, and young adults. Suicide is a known risk of depression and some other psychiatric disorders. Call your doctor right away if you have new or worsening depression symptoms, unusual changes in behavior, or thoughts of suicide. Be especially observant within the first few months of treatment or after a change in dose. Approved only for adults 18 and over.
What should I talk about with my healthcare provider?
Patients on antidepressants and their families or caregivers should watch for new or worsening depression symptoms, unusual changes in behavior, thoughts of suicide, anxiety, agitation, panic attacks, difficulty sleeping, irritability, hostility, aggressiveness, impulsivity, restlessness, or extreme hyperactivity. Call your healthcare provider right away if you have thoughts of suicide or if any of these symptoms are severe or occur suddenly. Be especially observant within the first few months of antidepressant treatment or whenever there is a change in dose.
Who should NOT take Cymbalta?
You should not take Cymbalta if:
* You have recently taken a type of antidepressant called a monoamine oxidase inhibitor (MAOI)
* You have uncontrolled narrow-angle glaucoma (increased eye pressure)
* You are taking Mellaril® (thioridazine)
What other important information should I discuss with my healthcare provider?
Before starting Cymbalta, talk with your healthcare provider:
* about all of your medical conditions, including kidney or liver problems, glaucoma, diabetes, seizures, or if you have bipolar disorder. Cymbalta may worsen a type of glaucoma or the control of blood sugar in some patients with diabetes
* about your alcohol use
* if you are taking nonprescription or prescription medicines, including those for migraine, to address a possible life-threatening condition
* if you are taking NSAID pain relievers, aspirin, or blood thinners. Use with Cymbalta may increase bleeding risk
* if you are pregnant, plan to become pregnant during therapy, or are breastfeeding an infant
While taking Cymbalta, talk with your healthcare provider:
* if you have itching, right upper belly pain, dark urine, yellow skin/eyes, or unexplained flu-like symptoms, which may be signs of liver problems. Severe liver problems, sometimes fatal, have been reported
* if you have high fever, confusion, and stiff muscles to address a possible life-threatening condition
* before stopping Cymbalta or changing your dose
* if you experience dizziness or fainting upon standing, especially when first starting Cymbalta or when increasing the dose
* about your blood pressure. Cymbalta can increase your blood pressure. Your healthcare provider should check your blood pressure prior to and while taking Cymbalta
* if you experience headache, weakness, confusion, problems concentrating, memory problems, or feel unsteady while taking Cymbalta which may be signs of low sodium levels
* if you develop problems with urine flow
If you have any questions, talk to your healthcare provider before taking Cymbalta.
What are the possible side effects of Cymbalta?
The most common side effect of Cymbalta was nausea. Other common side effects included dry mouth, sleepiness, constipation, decreased appetite, and, increased sweating. This is not a complete list of side effects.
Other safety information about Cymbalta:
Cymbalta may cause sleepiness and dizziness. Until you know how Cymbalta affects you, you should not drive a car or operate hazardous machinery.
Please read additional Safety Information and Boxed Warning for a complete list.
Prescribing Information | Safety Information and Boxed Warning | Medication Guide | Multimedia Help | Glossary | Site Map | Patient Assistance Program
Lilly
4's gettin hit well
ur nutz/funny lol..good ol lj,,,ol red
Ok ok, nobody throw defoamer..
U wanna long term investment! Siri gonna blow within the nxt "when ever"
wish i would of could of should held my .11s
Yes, g1 kitty, now ur down 28%.
Glad my life savn's ant here..
Dear Rhino,
lol jk, what to expect from QASP
u have a target,,gettn' alatta actionta...
gonna b 1 huge cup & handle,,chaaaaa chiiiin.
.o445 its a start c what happens
up %1000
on post this year lol
ouch so far so good....
like many others ABK up .51cents
ABK up .51 cents ouchh.......
Lol,, thx
NO x 3
:>}
YRCW from a post on their board
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=48763314
What wuz its all time high?
X-a-Lent PWEB!!!!
45s hittin hard, nice support if sellers dont kill...
Skechy shit...thats y i bought in @42's..livin on the edge lol
hip hip hurray with a monster buy
scam or no scam, she'll move regaurdles'
lol,, hopin to jump in soon myself
PRMO U HEARD IT 2ND
accum started
well MT. 3's r up!
still cant bliv this is under many $$$$?